Next-Generation Sequencing (NGS) Kits Market was valued at USD 7.5 Billion in 2022 and is projected to reach USD 15 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Looking ahead from 2023 to 2033, the NGS kits market is poised for even more substantial growth. Projections indicate that the market could reach USD 30.01 billion by 2030, growing at a CAGR of 20% during the forecast period. This anticipated surge is driven by the expanding applications of NGS in personalized medicine, non-invasive prenatal testing, and infectious disease research. The versatility of NGS technologies in addressing diverse research and clinical needs is a major driver of market expansion.
Moreover, the integration of NGS into routine clinical practice is expected to become more prevalent, especially in oncology for tumor profiling and in reproductive health for non-invasive prenatal testing. The development of user-friendly platforms and continuous improvements in sequencing technologies are making NGS more efficient and accessible, reducing the complexity and cost of sequencing, and making it a viable option for smaller laboratories and new market entrants.
In my experience, the advancements in NGS technologies have been remarkable. The decreasing costs and increasing speed of sequencing have opened new avenues in research and diagnostics. The ability to obtain comprehensive genomic data swiftly has revolutionized our approach to understanding diseases and developing personalized treatment plans. The future of NGS holds immense potential, and staying abreast of these developments is crucial for professionals in the field.
Get an In-Depth Research Analysis of the Global Next-Generation Sequencing (NGS) Kits Market Size And Forecast [2025-2032]
Between 2018 and 2022, the Next-Generation Sequencing (NGS) kits market experienced significant growth, driven by technological advancements and increased applications in various fields. The market's expansion was evident in its valuation, reaching USD 5.2 billion in 2023, with projections to grow at a CAGR of 11.7% during the forecast period. This growth was primarily attributed to the rising adoption of NGS technologies in clinical diagnostics, drug discovery, and agricultural research.
During this period, the decline in sequencing costs made NGS more accessible to a broader range of research and clinical laboratories. The increasing prevalence of genetic disorders and cancers necessitated advanced diagnostic tools, further propelling the demand for NGS kits. Additionally, technological innovations improved sequencing accuracy and speed, enhancing the efficiency and appeal of NGS applications.
Foundation Medicine
Thermo Fisher Scientific
Illumina
MSKCC
Nanjing Geneseeq
Burning Rock Biotech
Novogene
Amoydxmed
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Next-Generation Sequencing (NGS) Kits Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Next-Generation Sequencing (NGS) Kits Market
Hospitals and Clinics
Biopharma Companies
Research Organizations
Others
Based on Types the Market is categorized into Below types that held the largest Next-Generation Sequencing (NGS) Kits market share In 2023.
BRCA
EGFR
BRAF
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Next-Generation Sequencing (NGS) Kits Market Research Analysis
1. Introduction of the Global Next-Generation Sequencing (NGS) Kits Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Next-Generation Sequencing (NGS) Kits Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Next-Generation Sequencing (NGS) Kits Market, By Type
6. Global Next-Generation Sequencing (NGS) Kits Market, By Application
7. Global Next-Generation Sequencing (NGS) Kits Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Next-Generation Sequencing (NGS) Kits Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/